Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Kane

Showing results (1-10 of 665) with videos related to

Pageof 67
Sort By:
The Journal of Clinical Psychiatry|July 18, 2006
Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)John M Kane
Current Opinion in Oncology|June 10, 2004
Surveillance strategies for patients following surgical resection of soft tissue sarcomasJohn M Kane
The Journal of Clinical Psychiatry|December 19, 2003
Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studiesJohn M Kane
The Journal of Clinical Psychiatry|January 20, 2004
Oral ziprasidone in the treatment of schizophrenia: a review of short-term trialsJohn M Kane
Journal of Clinical Psychopharmacology|September 13, 2022
A New Treatment Paradigm: Targeting Trace Amine-Associated Receptor 1 (TAAR1) in SchizophreniaJohn M Kane
CNS Spectrums|November 7, 2007
Treatment adherence and long-term outcomesJohn M Kane
The Journal of Clinical Psychiatry|August 9, 2008
Sedation as a side effect of the treatment of mental disordersJohn M Kane
The Surgical Clinics of North America|August 11, 2022
The Suspicious Soft Tissue MassJohn M Kane
Evidence-Based Mental Health|January 31, 2014
Financial incentives improve adherence to maintenance antipsychotic treatmentJohn M Kane
The Journal of Clinical Psychiatry|January 6, 2012
Recent advances in treatments for schizophreniaJohn M Kane
Pageof 67

Showing results (1-10 of 665) with videos related to

Sort By:
Pageof 67
The Journal of Clinical Psychiatry|July 18, 2006
Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)John M Kane
Current Opinion in Oncology|June 10, 2004
Surveillance strategies for patients following surgical resection of soft tissue sarcomasJohn M Kane
The Journal of Clinical Psychiatry|December 19, 2003
Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studiesJohn M Kane
The Journal of Clinical Psychiatry|January 20, 2004
Oral ziprasidone in the treatment of schizophrenia: a review of short-term trialsJohn M Kane
Journal of Clinical Psychopharmacology|September 13, 2022
A New Treatment Paradigm: Targeting Trace Amine-Associated Receptor 1 (TAAR1) in SchizophreniaJohn M Kane
CNS Spectrums|November 7, 2007
Treatment adherence and long-term outcomesJohn M Kane
The Journal of Clinical Psychiatry|August 9, 2008
Sedation as a side effect of the treatment of mental disordersJohn M Kane
The Surgical Clinics of North America|August 11, 2022
The Suspicious Soft Tissue MassJohn M Kane
Evidence-Based Mental Health|January 31, 2014
Financial incentives improve adherence to maintenance antipsychotic treatmentJohn M Kane
The Journal of Clinical Psychiatry|January 6, 2012
Recent advances in treatments for schizophreniaJohn M Kane
Pageof 67